Intrexon reported $12.67M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US $ 18.91M 39K
Amgen AMGN:US $ 1.33B 99M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
AstraZeneca AZN:LN 3.27B 209M
Bluebird Bio BLUE:US $ 36.69M 588K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Chemocentryx CCXI:US $ 28.18M 2.17M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Heron Therapeutics HRTX:US $ 32.12M 836K
Immunogen IMGN:US $ 23.79M 7.14M
Intrexon XON:US $ 12.67M 6.91M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Macrogenics MGNX:US $ 13.67M 2.58M
Mannkind MNKD:US $ 26.04M 5.35M
Merk MRK:US $ 2.42B 118M
Novartis NOVN:VX 3.59B 91M
Peregrine Pharmaceuticals PPHM:US $ 5.92M 97K
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Thermo Fisher Scientific TMO:US $ 1.74B 537M
Veracyte VCYT:US $ 39.96M 4.18M
Xencor XNCR:US $ 11.09M 182K
YTE INCY:US $ 253.28M 43.69M
Ziopharm Oncology ZIOP:US $ 3.43M 76K